These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 20153412)
1. Cell-specific targeting in the mouse inner ear using nanoparticles conjugated with a neurotrophin-derived peptide ligand: potential tool for drug delivery. Roy S; Johnston AH; Newman TA; Glueckert R; Dudas J; Bitsche M; Corbacella E; Rieger G; Martini A; Schrott-Fischer A Int J Pharm; 2010 May; 390(2):214-24. PubMed ID: 20153412 [TBL] [Abstract][Full Text] [Related]
2. Targeting of polymeric nanoparticles to lung metastases by surface-attachment of YIGSR peptide from laminin. Sarfati G; Dvir T; Elkabets M; Apte RN; Cohen S Biomaterials; 2011 Jan; 32(1):152-61. PubMed ID: 20889205 [TBL] [Abstract][Full Text] [Related]
3. Transsynaptic delivery of nanoparticles to the central auditory nervous system. Praetorius M; Brunner C; Lehnert B; Klingmann C; Schmidt H; Staecker H; Schick B Acta Otolaryngol; 2007 May; 127(5):486-90. PubMed ID: 17453474 [TBL] [Abstract][Full Text] [Related]
4. LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors. Luo G; Yu X; Jin C; Yang F; Fu D; Long J; Xu J; Zhan C; Lu W Int J Pharm; 2010 Jan; 385(1-2):150-6. PubMed ID: 19825404 [TBL] [Abstract][Full Text] [Related]
5. Targeting of nanoparticles to the clathrin-mediated endocytic pathway. Harush-Frenkel O; Debotton N; Benita S; Altschuler Y Biochem Biophys Res Commun; 2007 Feb; 353(1):26-32. PubMed ID: 17184736 [TBL] [Abstract][Full Text] [Related]
6. Intratympanic delivery of oligoarginine-conjugated nanoparticles as a gene (or drug) carrier to the inner ear. Yoon JY; Yang KJ; Kim DE; Lee KY; Park SN; Kim DK; Kim JD Biomaterials; 2015 Dec; 73():243-53. PubMed ID: 26414408 [TBL] [Abstract][Full Text] [Related]
8. Follicle-stimulating hormone peptide can facilitate paclitaxel nanoparticles to target ovarian carcinoma in vivo. Zhang XY; Chen J; Zheng YF; Gao XL; Kang Y; Liu JC; Cheng MJ; Sun H; Xu CJ Cancer Res; 2009 Aug; 69(16):6506-14. PubMed ID: 19638590 [TBL] [Abstract][Full Text] [Related]
9. Targeting the urokinase plasminogen activator receptor with synthetic self-assembly nanoparticles. Wang M; Löwik DW; Miller AD; Thanou M Bioconjug Chem; 2009 Jan; 20(1):32-40. PubMed ID: 19099499 [TBL] [Abstract][Full Text] [Related]
10. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting. Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635 [TBL] [Abstract][Full Text] [Related]
11. A quantitative evaluation of the molecular binding affinity between a monoclonal antibody conjugated to a nanoparticle and an antigen by surface plasmon resonance. Debotton N; Zer H; Parnes M; Harush-Frenkel O; Kadouche J; Benita S Eur J Pharm Biopharm; 2010 Feb; 74(2):148-56. PubMed ID: 19835957 [TBL] [Abstract][Full Text] [Related]
12. Brain-targeting mechanisms of lactoferrin-modified DNA-loaded nanoparticles. Huang R; Ke W; Han L; Liu Y; Shao K; Ye L; Lou J; Jiang C; Pei Y J Cereb Blood Flow Metab; 2009 Dec; 29(12):1914-23. PubMed ID: 19654588 [TBL] [Abstract][Full Text] [Related]
13. Survival, synaptogenesis, and regeneration of adult mouse spiral ganglion neurons in vitro. Wei D; Jin Z; Järlebark L; Scarfone E; Ulfendahl M Dev Neurobiol; 2007 Jan; 67(1):108-22. PubMed ID: 17443776 [TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells. Li SD; Huang L Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857 [TBL] [Abstract][Full Text] [Related]
15. A specific drug targeting system based on polyhydroxyalkanoate granule binding protein PhaP fused with targeted cell ligands. Yao YC; Zhan XY; Zhang J; Zou XH; Wang ZH; Xiong YC; Chen J; Chen GQ Biomaterials; 2008 Dec; 29(36):4823-30. PubMed ID: 18824258 [TBL] [Abstract][Full Text] [Related]
16. The targeting of surface modified silica nanoparticles to inflamed tissue in experimental colitis. Moulari B; Pertuit D; Pellequer Y; Lamprecht A Biomaterials; 2008 Dec; 29(34):4554-60. PubMed ID: 18790531 [TBL] [Abstract][Full Text] [Related]
17. HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting. Zhang Z; Chen J; Ding L; Jin H; Lovell JF; Corbin IR; Cao W; Lo PC; Yang M; Tsao MS; Luo Q; Zheng G Small; 2010 Feb; 6(3):430-7. PubMed ID: 19957284 [TBL] [Abstract][Full Text] [Related]
18. Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes. Dinauer N; Balthasar S; Weber C; Kreuter J; Langer K; von Briesen H Biomaterials; 2005 Oct; 26(29):5898-906. PubMed ID: 15949555 [TBL] [Abstract][Full Text] [Related]
19. Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells. Messerschmidt SK; Musyanovych A; Altvater M; Scheurich P; Pfizenmaier K; Landfester K; Kontermann RE J Control Release; 2009 Jul; 137(1):69-77. PubMed ID: 19306900 [TBL] [Abstract][Full Text] [Related]